Floatz logo

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-

Rapid Eye Movement Sleep Behavior Disorder

Ruijin HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Rapid Eye Movement Sleep Behavior Disorder cohort.

Asset / SponsorPhaseRating
Bifidobacterium
Beijing Friendship Hospital
Phase 4BB
BACILLUS LICHENIFORMIS
Beijing Friendship Hospital
Phase 4BB
FALLYPRIDE
Ruijin Hospital
D

Same molecule, other indications

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:

Alzheimer DementiaDormant
BB
Indicative ·
66 / 100
View asset →
Essential TremorDormant
B
Indicative ·
63 / 100
View asset →
Breast CancerDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →